[Sclerosing of varicose veins and additional medication. Are disease course and results affected by combined therapy? An experience report].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004087:Dihydroergotamine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012431:Rutin / Q000031:analogs & derivatives*; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D014648:Varicose Veins / Q000188:drug therapy*
D004338:Drug Combinations; D006896:Hydroxyethylrutoside; D012597:Sclerosing Solutions; D004087:Dihydroergotamine; D012431:Rutin; C026861:Venelbin
Varizensklerosierung und Zusatzmedikation. Sind Verlauf und Ergebnisse durch kombinierte Therapie zu beeinflussen? - Ein Erfahrungsbericht.